论文部分内容阅读
毛细支气管炎(简称毛支炎)是儿科常见病,多发生于2岁以下婴幼儿,呼吸道合胞病毒(RSV)是主要病原。本文以探讨IgG亚类为主的RSV毛支炎的体液免疫变化,并观察应用国产静滴丙种球蛋白(Intravenousimmunoglobulin,IVIG)治疗的临床效果。对象和方法一、对象 72例为我院呼吸病房住院的患儿,经血清RSV-IgM测定均确诊为RSV感染,随机选择分为两组。治疗组(IVIG和抗生素、给氧、激素)29例,男19例,女10例,年龄29天～1.5岁(平均4.67月);对照组43例,接受一般治疗,男30例,女13例,年龄33天～2岁(平均1.92月)。两组
Bronchiolitis (gross bronchitis) is a common pediatric disease, occurred in infants and children under 2 years of age, respiratory syncytial virus (RSV) is the main pathogen. This article is to investigate the humoral immunity of RSV bronchiolitis, which is mainly composed of IgG subclasses, and to observe the clinical effect of the treatment with domestic intravenous gamma globulin (IVIG). Subjects and methods First, the object 72 cases for our hospital respiratory ward children were diagnosed by RSV-IgM serum RSV infection were randomly divided into two groups. The treatment group (IVIG and antibiotics, oxygen, hormones) in 29 cases, 19 males and 10 females, aged 29 days to 1.5 years (mean 4.67 months); control group of 43 patients received general treatment, 30 males and 13 females Cases, aged 33 days to 2 years (mean 1.92 months). Two groups